Breast Prostheses Overview
After a mastectomy or lumpectomy for the treatment of breast cancer, you can achieve a symmetrical appearance again by using a breast prosthesis. There are several types available, in various skin tones and sizes. Learn more about types of breast prostheses. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - February 24, 2014 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Breast Cancer Theraputic Surgery Options
What is a lumpectomy? What are surgical margins, and why should they be clear? Read about what kind of scar to expect and how having a lumpectomy will change your breast. Page 2. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - February 21, 2014 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Sex After Breast Cancer
In supportive relationships, it usually returns to pre-diagnosis levels in two years.read more (Source: Psychology Today Sex Center)
Source: Psychology Today Sex Center - February 16, 2014 Category: Sexual Medicine Authors: Michael Castleman, M.A. Tags: Anxiety Relationships Resilience Sex sex after breast cancer sex and lumpectomy sex and mastectomy Source Type: news
Guideline on Lumpectomy Margins Should Reduce Re-excision Guideline on Lumpectomy Margins Should Reduce Re-excision
A new guideline on margins in breast cancer surgery for women with early-stage disease undergoing lumpectomy should reduce the re-excision rates. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 11, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Lumpectomy: Aim for No Ink on Tumor (CME/CE)
(MedPage Today) -- Surgical margins with no ink on the tumor have the lowest risk of ipsilateral breast cancer recurrence and represent the clinical standard for management of early disease, according to a new consensus guideline. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 10, 2014 Category: Hematology Source Type: news
Mixed Results for Brachytherapy in Breast Cancer (CME/CE)
(MedPage Today) -- Older breast cancer patients had an increased rate of subsequent mastectomy if they received brachytherapy instead of external-beam radiation therapy after lumpectomy but fared better than patients who received no radiation, investigators reported. (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 7, 2014 Category: Surgery Source Type: news
Survival Better With Lumpectomy Than With MastectomySurvival Better With Lumpectomy Than With Mastectomy
A large observational study of early breast cancer indicates that disease-specific survival is better with breast-conserving therapy. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 16, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Cosmetic outcomes after breast-conserving therapy may vary by race
(Wolters Kluwer Health) As perceived by both patients and doctors, the cosmetic results after "lumpectomy" for breast cancer differ for African-American versus Caucasian women, suggests a pilot study in the Plastic and Reconstructive Surgery -- Global Open, the official open-access medical journal of the American Society of Plastic Surgeons. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2014 Category: Cancer & Oncology Source Type: news
Breast surgeons report improved visualization of treatment area for radiation therapy
The BioZorb™ three-dimensional surgical marker dramatically improves visualization of the treatment area for radiation planning and therapy, according to a presentation at the prestigious San Antonio Breast Cancer Symposium 2013. The scientific poster reports that the tissue marker is easy to place, safe to use and well tolerated by patients. In the presentation, a series of consecutive early-stage breast cancer patients was implanted with the device at the time of lumpectomy. The 3D BioZorb marker was reported to provide clinical advantages for surgeons and radiation oncologists. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 19, 2013 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news
New breast cancer study: Results of the TARGIT-A clinical trial
A new clinical trial for breast cancer, published in The Lancet, shows that a single fraction of targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM® at time of lumpectomy is non-inferior to traditional external beam radiation (EBRT) delivered over three to six weeks after breast conserving surgery, for a select group of patients."The most important benefit of TARGIT for a woman with breast cancer is that it allows her to complete her entire local treatment at the time of her operation, with lower toxicity to the breast, the heart and other organs. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 3, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Breast cancer radiotherapy during surgery could ease treatment
Two new studies published in leading journals this week show how a "one-stop" targeted radiotherapy given during lumpectomy may offer some patients with early-stage breast cancer a viable alternative to current treatments. Experts say the approach looks promising but more research is needed to identify which patients are most likely to benefit. Most women with breast cancer who undergo lumpectomy or partial mastectomy also undergo a course of radiation delivered to the whole of the affected breast... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
"One-stop" radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer
Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures - which require women to attend daily radiotherapy sessions for weeks after surgery - for some women undergoing surgery for early breast cancer. Most women who undergo partial mastectomy (lumpectomy) surgery for breast cancer also complete a course of radiotherapy delivered to the whole of the affected breast (called external beam radiotherapy, EBRT)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 11, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Younger Breast Cancer Patients Choosing to Get Bilateral Mastectomies
This trend even includes some young women with very-early-stage breast cancers in one breast that can be well managed surgically with lumpectomy and radiation. Do they need this surgery? (Source: Breast Cancer Chronicles)
Source: Breast Cancer Chronicles - November 3, 2013 Category: Consumer Health Advice Authors: Lillie Shockney Source Type: news
Video: New tool detects breast cancer, limits additional surgeries
More than 230,000 U.S. women are diagnosed with breast cancer each year. Many choose a lumpectomy to remove the cancerous tissue. Now a new tool in the operating room may save women from follow-up surgery. CBS News' Teresa Garcia reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 13, 2013 Category: Consumer Health News Source Type: news
Beware Of Cancer Metastasizing To Your Wallet
Joanne Reed’s breast cancer was discovered at an early stage, early enough that her doctors would be able to remove the tumor with surgery (either a mastectomy or a lumpectomy) and then, with a touch of chemo, she would face a decent chance of living out her life without a recurrence. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 16, 2013 Category: Pharmaceuticals Authors: Peter Ubel Source Type: news
